Asthma

SAN ANTONIO — Clinicians and researchers are beginning to explore whether asthma remission is possible, Corinne Young, FNP-C, FCCP, said during her presentation at the 16th Annual Allergy, Asthma & Immunology CME Conference.

Adults with severe asthma using a biologic therapy for the first time experienced changes in body composition parameters at 1 year, according to a research letter published in Annals of the American Thoracic Society.

SAN ANTONIO — Pulmonary function testing may be routine, but it still comes with challenges, Nicole Soucy, PA-C, said at the Association of PAs in Allergy, Asthma & Immunology 16th annual conference.

SAN ANTONIO — Personalized treatment strategies can help providers overcome barriers to biologic care for patients with asthma, Lukena Karkhanis, MD, said at the 16th Annual Allergy, Asthma & Immunology CME Conference.

The FDA has approved Palforzia, an oral immunotherapy designed to protect children aged 1 to 3 years with peanut allergies from reactions caused by accidental exposure, according to a press release.

School-aged children residing in historically redlined neighborhoods had higher exposures to pollutants and worse asthma severity, according to a study in The Journal of Allergy and Clinical Immunology.

SAN ANTONIO — Climate change is making allergies and asthma worse, but patient education and professional advocacy may mitigate these impacts, Jeffrey Demain, MD, FAAAAI, FACAAI, FAAP, told Healio.

SAN ANTONIO — Career development as well as continuing education and connections are among the goals of the Association of PAs in Allergy, Asthma & Immunology, according to incoming president Heather O’Connell, PA-C.

Communities with warehouses were exposed to an average of 17.9% more nitrogen dioxide than other communities, according to a study published in Nature Communications.

Healio has compiled July’s most-read news in asthma and allergy.